Back to Search
MARGARET DUVIC, D.O.
D.O.
Pediatrics Physician
NPI: 1740442151Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.
PMID 17594194·Expert Opin Investig Drugs·2007
6-review
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).
PMID 16960145·Blood·2007
3-trial
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
PMID 17052486·J Am Acad Dermatol·2006
3-trial
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
PMID 16879770·Clin Lymphoma Myeloma·2006
3-trial
Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK).
PMID 11970761·Clin Lymphoma·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 315 N SAN SABA, #1075
SAN ANTONIO, TX 78207 - Phone
- (210) 223-3543
Quick Facts
- NPI
- 1740442151
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile